BR9605434A - Derivados de purin-6-ona - Google Patents

Derivados de purin-6-ona

Info

Publication number
BR9605434A
BR9605434A BR9605434A BR9605434A BR9605434A BR 9605434 A BR9605434 A BR 9605434A BR 9605434 A BR9605434 A BR 9605434A BR 9605434 A BR9605434 A BR 9605434A BR 9605434 A BR9605434 A BR 9605434A
Authority
BR
Brazil
Prior art keywords
purin
derivatives
Prior art date
Application number
BR9605434A
Other languages
English (en)
Inventor
Ulrich Niewoehner
Helmuth Schuetz
Elisabeth Perzborn
Joachim Huetter
Erwin Bischoff
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9605434A publication Critical patent/BR9605434A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
BR9605434A 1995-11-06 1996-11-06 Derivados de purin-6-ona BR9605434A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19541264A DE19541264A1 (de) 1995-11-06 1995-11-06 Purin-6-on-derivate

Publications (1)

Publication Number Publication Date
BR9605434A true BR9605434A (pt) 1998-08-04

Family

ID=7776713

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9605434A BR9605434A (pt) 1995-11-06 1996-11-06 Derivados de purin-6-ona

Country Status (23)

Country Link
US (1) US5861396A (pt)
EP (1) EP0771799A1 (pt)
JP (1) JPH09124648A (pt)
KR (1) KR970027082A (pt)
AR (1) AR004545A1 (pt)
AU (1) AU720305B2 (pt)
BR (1) BR9605434A (pt)
CA (1) CA2189401A1 (pt)
CO (1) CO4770977A1 (pt)
CZ (1) CZ325096A3 (pt)
DE (1) DE19541264A1 (pt)
EE (1) EE9600172A (pt)
HU (1) HU217691B (pt)
IL (1) IL119559A0 (pt)
MX (1) MX9605371A (pt)
NO (1) NO964667L (pt)
NZ (1) NZ299683A (pt)
PL (1) PL316816A1 (pt)
SG (1) SG64953A1 (pt)
SK (1) SK142596A3 (pt)
TR (1) TR199600883A2 (pt)
TW (1) TW360656B (pt)
ZA (1) ZA969278B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2315736A1 (en) * 1998-01-05 1999-07-15 Eisai Co., Ltd. Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus
DE19838705A1 (de) 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
US20050070499A1 (en) * 1999-11-08 2005-03-31 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
IL139456A0 (en) * 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
JP2004505054A (ja) 2000-08-01 2004-02-19 バイエル　アクチェンゲゼルシャフト 知覚を改善する医薬品としての選択的ｐｄｅ２インヒビター
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
NZ524572A (en) * 2000-09-06 2004-08-27 Tanabe Seiyaku Co Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions
DE10064105A1 (de) 2000-12-21 2002-06-27 Bayer Ag Neue Substituierte Imidazotriazinone
JP4179784B2 (ja) * 2001-02-15 2008-11-12 田辺三菱製薬株式会社 口腔内速崩壊性錠
PL364625A1 (en) 2001-02-23 2004-12-13 Merck & Co, Inc. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
JP2005508978A (ja) * 2001-11-02 2005-04-07 ファイザー・プロダクツ・インク Ｐｄｅ９阻害薬によるインスリン抵抗性症候群及び２型糖尿病の治療
US20060106037A1 (en) * 2003-03-04 2006-05-18 Thomas Bar Purin-6-one-derivatives
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
US20060229242A1 (en) * 2003-08-28 2006-10-12 Altana Phazma Ag Composition comprising a pulmonary surfactant and a pde2 inhibitor
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
ATE412648T1 (de) * 2005-03-21 2008-11-15 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
US20080214622A1 (en) * 2005-03-21 2008-09-04 Alan Daniel Brown Substituted Triazole Derivatives As Oxytocin Antagonists
EP1917257A1 (en) * 2005-08-10 2008-05-07 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
JP6696904B2 (ja) 2014-01-08 2020-05-20 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 製剤および医薬組成物
JP6608934B2 (ja) 2014-12-06 2019-11-20 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物
JP6608933B2 (ja) 2014-12-06 2019-11-20 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
IL76546A (en) * 1984-10-12 1988-12-30 Warner Lambert Co 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them
JPH01501478A (ja) * 1986-11-25 1989-05-25 インスティテュト　オルガニチェスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスアール ９―置換グアニン
IT1241452B (it) * 1990-06-28 1994-01-17 Sigma Tau Ind Farmaceuti Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
AU7053296A (en) 1997-05-15
SK142596A3 (en) 1997-05-07
NZ299683A (en) 1998-09-24
AU720305B2 (en) 2000-05-25
CO4770977A1 (es) 1999-04-30
HUP9603071A2 (en) 1997-05-28
JPH09124648A (ja) 1997-05-13
SG64953A1 (en) 1999-05-25
AR004545A1 (es) 1998-12-16
ZA969278B (en) 1997-06-02
MX9605371A (es) 1997-05-31
DE19541264A1 (de) 1997-05-07
TR199600883A2 (tr) 1997-05-21
HUP9603071A3 (en) 1998-04-28
EP0771799A1 (de) 1997-05-07
IL119559A0 (en) 1997-02-18
HU217691B (hu) 2000-03-28
TW360656B (en) 1999-06-11
CA2189401A1 (en) 1997-05-07
EE9600172A (et) 1997-06-16
NO964667D0 (no) 1996-11-05
KR970027082A (ko) 1997-06-24
NO964667L (no) 1997-05-07
US5861396A (en) 1999-01-19
CZ325096A3 (en) 1997-06-11
HU9603071D0 (en) 1996-12-30
PL316816A1 (en) 1997-05-12

Similar Documents

Publication Publication Date Title
PT833828E (pt) Derivados de rapamicina
DE69611361D1 (de) Chinazolin-derivate
DE69522717D1 (de) Chinazolinderivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698T2 (de) Chinazolin-derivate
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
BR9609682A (pt) Foto-desinfetantes de baixa nuança
BR9605434A (pt) Derivados de purin-6-ona
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
BR9509793A (pt) Derivados de tiofeneno
DE69601527T2 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
PT856007E (pt) Derivados de ciclopeptidos
BR9610597A (pt) Derivados de diarilalcenilamina
DE69627830D1 (de) Pyrazol-derivate
DK0723963T3 (da) 4-Amino-benzoylguanidin-derivater
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
PT843675E (pt) Derivados de aza-antraciclinona
BR9506618A (pt) Derivados de difeniloxazolinas
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate
PT839024E (pt) Formulacoes de monensina
DE69620514T2 (de) 5-aminoflavon-derivate
ATA45796A (de) Lysin-prolin-derivate

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]